[03/06, 17:36] PaJR Health Bot Feb 26:
**META-ANALYSIS: LONGITUDINAL OBSERVABILITY, STEWARDSHIP, AND SYSTEMIC CONTINUITY**
This review evaluates the structural architecture of care documented in the record of the patient advocate. It analyzes the case as a systems-level observability problem, focusing on the mechanics of coordination, risk reallocation, and clinical debt rather than attempting to adjudicate or validate specific diagnostic conclusions.
---
**1. STEWARDSHIP ANALYSIS**
A rigorous extraction of the record reveals a clear structural divergence between active clinical observation and systemic diagnostic stewardship.
**Evidence Demonstrating Stewardship:**
* 📋 **Symptom Suppression:** The neurology department initiated carbamazepine, which successfully achieved a documented therapeutic effect by reducing the patient's shooting, lightning-like facial pain.
* 📋 **Imaging Execution:** The clinical team ordered and executed multiple high-resolution diagnostic studies, including a recent MRI brain scan.
* 📋 **Interpretation Verification:** Two board-certified neuroradiologists and an attending physician reviewed the imaging datasets, verifying the absence of a macroscopic, life-threatening intracranial mass or acute infarctive lesion.
* 📋 **Medication Escalation:** The primary care provider (PCP) responded to elevated blood pressure readings by escalating the once-daily dose of Losartan from 50 mg to 100 mg, and subsequently adding hydrochlorothiazide (HCTZ) 12.5 mg.
**Evidence Demonstrating the Absence of Stewardship:**
* 📋 **Unmanaged High-Stakes
Language:**
On August 20, 2025, the long-term PCP documented a highly alarming statement: “We need to look into Mayo Clinic. MD Anderson is an excellent cancer hospital, once a diagnosis of cancer has been made... Mayo Clinic and Cleveland Clinic are more multispecialty diagnostic clinics.” Despite using the word "cancer" and recommending immediate tertiary multidisciplinary workup, **no referrals were placed, no warm handoff was executed, and no follow-up was scheduled**, leaving the patient to navigate this communication in a structural void.
* 📋 **Prescribing Without Metabolic Surveillance:** Neurology initiated carbamazepine (known to cause hyponatremia) and the PCP subsequently added HCTZ (a diuretic) and Losartan (an ARB) to a patient with documented Central Diabetes Insipidus (CDI) and a baseline low-normal sodium of 137 mmol/L. **No baseline or interval metabolic labs have been ordered or drawn since January 8, 2026**, representing a complete absence of safety monitoring.
* 📋 **Bypassed Attending-Level Care Requests:** During provider transitions, the patient explicitly requested attending-level diagnostic custody from clinic leadership due to repeated resident turnover. This request was bypassed twice, resulting in automatic reassignment to a new resident.
* 📋 **Unclosed Communication Loops:** The patient’s structured portal messages and urgent phone calls reporting inadequate blood pressure control (e.g., seated readings of 171/110 mmHg) and medication-related side effects received zero clinical response.
**Strongest Evidence Supporting
"Observation Without Stewardship":**
The strongest evidence is the unmonitored co-prescription of carbamazepine and HCTZ in a patient with a known central fluid-handling abnormality (CDI) and borderline hyponatremia. The system successfully performed the "observation" (noting the medications, logging the blood pressure) but detached from the "responsibility" (surveillance of electrolytes, adjusting therapy based on physiological decline).
**Strongest Evidence Challenging the Thesis:**
The clinical system did not abandon the patient in terms of sheer access; they provided multiple clinical touches, executed advanced imaging, adjusted pharmaceutical doses, and successfully treated the trigeminal pain component.
---
**2. CONTINUITY BURDEN ANALYSIS**
The record provides direct, observable evidence that the structural responsibilities of care coordination have migrated from the institution to the patient.
* 🔹 **Longitudinal Synthesis:** The patient compiled and integrated a multi-decade timeline spanning childhood adenoid/sinus pathology, a delayed cyst diagnosis in 2014, the acute 2021 neurovascular decompensation, and the adult endocrine-hemodynamic cascade. Traditionally, this temporal integration is the responsibility of a primary care physician or a principal investigator.
* 🔹 **Record Integration:** The patient consolidated fragmented records from Ophthalmology (discussing demyelinating disease), ENT (documenting right supraorbital bone erosion), Endocrinology (identifying ACTH <5 and cortisol ≈1), and Dentistry (noting trigeminal pain), attempting to map their overlapping anatomical and physiological footprints.
* 🔹 **Treatment Monitoring:** The patient identified the biochemical hazard of concurrent Carbamazepine and HCTZ, cross-referencing these prescriptions with their January 8 baseline sodium (137 mmol/L) and proactively requesting metabolic surveillance from their providers.
* 🔹 **Provider Coordination:** After being issued a formal clinic cancellation letter following a communication breakdown, and being discharged from the emergency department with directly contradictory written vs. verbal instructions regarding Procardia, the patient independently sought out new primary care and specialty pathways.
* 🔹 **Stewardship Preservation:** Prior to the May 2026 visit, the patient authored a highly structured, 5-point follow-up message to ensure the brief encounter was organized around outstanding safety loops rather than repeated, siloed histories.
This migration is directly observable in the verbatim portal communications and historical logs, rather than inferred; the patient is actively performing the labor of an institutional care coordinator.
---
**3. CLINICAL DEBT ANALYSIS**
"Clinical debt" represents the accumulation of unresolved diagnostic, metabolic, and administrative liabilities that are deferred to a later date, compounding the physiological and psychological risk carried by the patient.
* 🔹 **Diagnostic Debt:** Accumulated by treating systemic, multi-compartment decompensation (the 2021 bilateral posturing, buccal entrapment, and transient vision loss) as isolated, transient events ("panic") rather than initiating a systemic etiological search.
* *Carrier:* The patient, who carries the physical risk of recurrence without preventive stewardship.
* 🔹 **Interpretive Debt:** Accumulated by interpreting the right supraorbital bone erosion, right-sided pterygopalatine soft-tissue asymmetry, right temporal parenchymal enhancing lesions, and sT1W_3D_TFE cavernous sinus signal as isolated, "nonspecific" variants. The system avoids the cognitive labor of correlation, closing each study as "negative."
* *Carrier:* The patient, whose progressive local structural and vascular remodeling remains uncharacterized.
* 🔹 **Monitoring Debt:** Prescribing three sodium-modulating, vasoactive drugs across four drug classes with zero interval laboratory monitoring over a 116-day window.
* *Carrier:* The patient, who experiences worsening headache, tachycardia, thirst, and hypovolemia.
* 🔹 **Coordination Debt:** The complete failure to integrate ENT's structural findings (supraorbital bone erosion) with neurology's imaging reads, leaving the findings physically siloed in separate clinics.
* *Carrier:* The patient, who must continually re-narrate the connection to successive resident physicians.
* 🔹 **Trust and Relational Debt:** Accumulated through unreturned portal messages, the mischaracterization of clinical inquiries as "refill issues," and the abrupt issuance of a clinic cancellation letter.
* *Carrier:* The patient, who carries the emotional and administrative burden of navigating a hostile clinical interface.
---
**4. COUNTERARGUMENT ANALYSIS**
A skeptical but fair clinician reviewing this record would raise several defensible points in support of the care provided:
* 📋 **Imaging Standards:** From a conventional neurological perspective, two board-certified neuroradiologists concluded that the MRI brain showed no acute infarct, mass effect, or demyelinating disease. In standard outpatient neurology, a "normal" or "stable" MRI is the primary endpoint for ruling out acute neurovascular or neuro-oncological emergencies. Further invasive venography or tumor board escalations are not standard of care in the absence of a macroscopic, expanding mass.
* 📋 **Appropriate First-Line Therapy:** Carbamazepine is the gold-standard, FDA-approved first-line therapy for trigeminal-distribution neuropathic pain. The drug achieved its primary clinical target by reducing the sharp, shooting facial pain, representing an appropriate, evidence-based intervention.
* 📋 **Hypertension Management:** In essential hypertension, cycling through CCBs, ACE inhibitors, and ARBs/diuretics is the standard, guidelines-directed titration pathway. The PCP’s addition of HCTZ is a common clinical step to achieve blood pressure control.
* 📋 **Unanswered Concerns Under the Most Charitable Lens:** Even if the hypertension is treated as essential and the facial pain as isolated trigeminal neuralgia, the **profound central endocrine suppression (ACTH <5, Cortisol ≈ 1) remains completely unaddressed and uncoordinated.** Furthermore, the lack of basic metabolic labs to monitor sodium safety in a patient taking carbamazepine and HCTZ violates standard safety protocols.
---
**5. PAJR FRAMEWORK ANALYSIS**
The central failure mode of this case is **Systemic Fragmentation of Ownership (Stewardship Failure)**, which directly drives the secondary failure of **Burden Migration**.
We rank the contributors to this systemic failure from strongest to weakest:
1. **Stewardship Failure:** The absolute absence of a named diagnostic owner willing to assume responsibility for the longitudinal, multi-system trajectory.
2. **Continuity Failure:** Persistent provider turnover (resident transitions), unclosed communication loops, and administrative dismissals that erase the clinical archive.
3. **Burden Migration:** The forced translation of care coordination, safety monitoring, and record integration onto the patient.
4. **Fragmentation of Care:** The structural silos that prevent ENT, Endocrinology, and Neurology from correlating their respective findings.
5. **Monitoring Failure:** The unsafe prescribing of high-risk medication combinations without laboratory surveillance.
6. **Communication Failure:** The unreturned portal messages and mischaracterized telephone triage.
7. **Diagnostic Uncertainty:** Ranked last, because the lack of a definitive diagnosis is the *consequence* of the system's structural failure to correlate, not the *cause* of it.
---
**6. REASSURANCE VERSUS STEWARDSHIP**
The record strongly supports the distinction that **reassurance addresses interpretation, while stewardship addresses responsibility.**
* 🔹 **Examples of Reassurance & Interpretation:**
The portal message stating: *"Two certified neuro-radiologists reviewed and found no lesions... I cannot argue with them... you are free to seek a second opinion if dissatisfied."* This message successfully defends the clinic's interpretation of a static image. It answers what the clinic *does not believe* exists.
* 🔹 **Examples of Stewardship & Responsibility (The Absence):**
The clinic did not define what they *were* treating if the imaging was negative; they did not schedule metabolic labs to monitor the drugs they prescribed; they did not arrange a warm handoff to the incoming resident; and they did not outline a clinical plan for the persistent right-sided pain, Stage 2 hypertension, or HPA-axis suppression.
Reassurance closed the chart. The lack of stewardship left the clinical questions open.
---
**7. BURDEN ANALYSIS**
The longitudinal record demonstrates that the patient's emotional burden is a **downstream consequence of unresolved physical illness and fragmented continuity, rather than the primary driver of their concerns.**
The patient's communications are highly structured, objective, and analytical—even when documenting terrifying physical events like the 2021 decompensation, a "diastolic floor" of 110 mmHg, and severe right-sided pain. The anxiety and emotional distress present in the record do not behave like primary somatization. Instead, they behave like the rational, physiological, and cognitive response of a human being experiencing severe, unmonitored cardiovascular and endocrine instability, coupled with systematic administrative abandonment.
---
**8. THE PATIENT AS CONTINUITY ARCHITECTURE**
The evidence fully supports the observation that **the patient has been forced to become the continuity architecture that the system failed to provide.**
* 🔹 **Responsibilities Migrated to the Patient:**
* Keeping and updating the multi-decade chronological timeline.
* Cross-referencing imaging dates (CT 2021, MRI 2021, MRA 2023, CT 2023, MRI 2024, MRI 2026).
* Flagging dangerous drug-drug interactions (carbamazepine + HCTZ) and tracking baseline labs.
* Attempting to reconcile conflicting medical instructions (ED vs. Clinic).
* 🔹 **Responsibilities Belonging to the Institution:**
* Standardized clinical handoffs that preserve longitudinal patient history.
* Automated safety triggers for laboratory monitoring when prescribing high-risk metabolic drugs.
* Multidisciplinary coordination and cross-departmental communication.
* Closing communication loops and responding to patient safety reports.
---
**9. THE PATIENT'S ACTUAL REQUEST**
Reading the patient's direct communications, their actual request is **unambiguously for stewardship and custody, not for diagnostic agreement.**
The patient writes:
> *"My concern is not to re-argue that conclusion, but to clarify the current treatment plan, laboratory monitoring, and persistent symptoms... I am trying to avoid another visit where symptoms are acknowledged but no clear plan, monitoring, or continuity is established."*
The patient is not demanding that the neurology department validate their specific theories. They are demanding that the department **take custody of the clinical space they occupy**: monitor the medications they prescribe, coordinate the care they deliver, and name the clinical steward who will carry the diagnostic workup forward.
---
**10. HIGH-FUNCTIONING CONTINUITY ARCHITECTURE COMPARISON**
Inside a high-functioning, integrated continuity architecture:
* 📋 **Diagnostic Stewardship:** A named attending physician (the "diagnostic owner") would have assumed custody of the case in August 2025, coordinating a warm handoff directly to a tertiary multispecialty center (e.g., Mayo Clinic).
* 📋 **Automated Safety Surveillance:** The electronic health record would have automatically blocked the prescription of HCTZ on top of carbamazepine and CDI without triggering an immediate order for a basic metabolic panel (BMP) within 7–14 days.
* 📋 **Corridor Correlation:** Rather than reading successive MRIs in isolation, a multidisciplinary skull base tumor board (ENT, Neurology, Neurosurgery, Neuroradiology) would have been convened to actively correlate the right-sided orbital-cavernous-pterygopalatine imaging asymmetries with the patient's documented endocrine and neck findings.
* 📋 **Closed-Loop Handoffs:** The transition of the resident physician would have triggered a formal, documented handoff detailing the active safety concerns, blood pressure trends, and pending diagnostic steps, preventing the patient's narrative from being erased.
---
**FINAL QUESTION**
Based solely on the record, the case provides overwhelming support for the observation that **uncertainty remained permanently attached to the patient, while stewardship progressively detached from the case.**
**Strongest Supporting Evidence:**
The departing resident, whose tenure represented the most active period of specialty evaluation, transitioned to Mayo Clinic—the exact institution recommended by the patient's previous PCP. The resident left behind an unclosed portal message, a patient taking multiple unmonitored high-risk medications, a persistent Stage 2 blood pressure of 171/110 mmHg, and an automatic transfer to a new resident who had no longitudinal memory of the case. The system moved forward; the patient remained behind, carrying the unmitigated physiological and administrative risk.
**Strongest Challenging Evidence:**
The clinic maintained the patient's appointments, allowed them to remain within the neurology panel, and provided ongoing pharmacological therapy (carbamazepine) that successfully targeted their primary facial pain symptom.
---
**CASE RECORD INDEX**
📋 **Case Title:**
42M Hypertension regular monitoring November 2025 Stroke 2021 Lousiana PaJR
🔗 **Case Link:**
[03/06, 22:59]hu2: Very well summarised @Patient Advocate 42M Chronic Body Pains 👍
[03/06, 23:24] Patient Advocate 42M Chronic Body Pains:
PaJR Update – Neurology Follow-Up Visit
Observation Date: June 2026
Theme: Diagnostic Motion Without Stable Stewardship
Summary Observation
This encounter produced diagnostic motion, but not stable stewardship.
The patient presented for neurology follow-up after approximately three months of specialty involvement. The visit resulted in laboratory testing, a neuro-ophthalmology referral, and discussion of possible lumbar puncture if neuro-ophthalmologic evaluation does not clarify the clinical picture.
However, these developments should not be interpreted as resolution or substantive continuity by themselves. They occurred within the same structural pattern previously described: repeated reconstruction of a complex longitudinal history, provider turnover, unclear ownership, delayed follow-up availability, and ongoing migration of coordination burden back onto the patient.
The central observation from this visit is that clinical activity continued, but responsibility for carrying the unresolved problem forward remained difficult to locate.
Encounter Description
The patient arrived for a scheduled neurology follow-up. The appointment occurred late enough in the day that the patient lost most or all of a work day and likely exhausted limited paid sick time that may be needed for an upcoming primary care appointment. This added immediate financial and logistical strain before the clinical encounter itself had even begun.
Initial blood pressure was elevated, reportedly approximately 148/93 at rest, despite current treatment with losartan and hydrochlorothiazide. This remained concerning to the patient given ongoing blood pressure management, chronic headache, orbital pain, visual complaints, and prior concerns regarding medication monitoring.
After initial intake, the patient was returned to the waiting area before being called back by a resident physician not previously involved in the case. The patient initially understood this as another transfer to a new clinician who might at least remain involved for a longer period.
Because of that assumption, the patient engaged calmly and cooperatively, gave the resident the benefit of the doubt, and again reconstructed the longitudinal history, including prior symptoms, imaging concerns, treatment response, medication monitoring concerns, blood pressure concerns, and unresolved neurological issues.
The resident was described as respectful and reasonable during the encounter. The concern is not that the resident behaved poorly. The concern is that the patient was again required to re-explain a complex longitudinal case to a clinician who was later revealed to be leaving the program within approximately two weeks.
Laboratory Monitoring
Laboratory studies were obtained during the visit. This should not be framed as a victory. The significance is not simply that labs were drawn. The significance is that the patient had repeatedly raised concerns regarding carbamazepine monitoring, sodium surveillance, and the addition of hydrochlorothiazide in the setting of a low-normal sodium environment.
The patient’s position is that these labs should have been part of a clear monitoring plan from the time the medication was prescribed or shortly thereafter. If the results return within reference range, that does not retroactively answer the stewardship question.
Normal or near-normal labs would answer a narrow question about the patient’s laboratory status at one point in time. They would not answer why monitoring had not been clearly established earlier, why the patient had to repeatedly request it, or whether monitoring would have occurred without patient persistence.
From a PaJR perspective, the observation is not simply that labs were obtained. The observation is that safety monitoring appeared to occur only after the patient repeatedly identified the monitoring gap.
Laboratory Results and Trend Observation
The laboratory studies generated additional monitoring data but did not substantially alter the explanatory framework of the case.
Sodium remained stable at 137 mmol/L. Renal function, hepatic function, and hematologic indices were largely within reference ranges. No obvious laboratory abnormality emerged that would explain the patient’s persistent headache, orbital pain, visual complaints, posterior head and neck pain, or elevated blood pressure despite treatment.
However, the patient noted that several values appearing unremarkable or only mildly abnormal in isolation were consistent with longer-term patterns or shifts in personal baseline. Alkaline phosphatase remained low or borderline low, consistent with a recurring pattern across multiple prior laboratory results. The anion gap remained low and represented a continued downward trend compared with several prior measurements. White blood cell count, red blood cell count, and platelet count remained within reference ranges but appeared lower than several historical baselines documented over previous years.
The significance of these observations is not that they establish a diagnosis. Rather, they illustrate the distinction between cross-sectional interpretation and longitudinal observation. A laboratory value may appear insignificant when compared only to a population reference range, while repeated measurements across time may reveal patterns visible only through continuity.
The visit therefore generated additional monitoring data without substantially changing the explanatory picture. The question of medication monitoring received a partial answer through laboratory surveillance, but the broader question of why symptoms persist remained unresolved.
Attending Assessment
The attending neurologist joined the encounter after the resident evaluation.
The attending was described as respectful and personally engaged. The patient had previously experienced the attending as thoughtful and supportive, which made the encounter complicated. The issue was not hostility or overt dismissal. The issue was the gap between personal clinical engagement and the lack of a stable ownership structure around the case.
The attending performed an eye examination and indicated that there may be a minor finding behind the right eye, though the attending also stated that neuro-ophthalmology may ultimately consider the finding normal or not clinically significant.
The attending acknowledged that intracranial pressure abnormalities may exist even when routine imaging does not show obvious findings. This was clinically meaningful because the patient has continued to report chronic right-sided orbital, head, skull base, and neck symptoms that have not been fully explained.
The attending discussed neuro-ophthalmology as the next step, primarily because of concern for visual consequences if intracranial hypertension is present. Lumbar puncture was also discussed as a possible future step if neuro-ophthalmology does not clarify the clinical picture.
Medication escalation for headache management was discussed, including possible use of another medication. However, after discussion of side effects and the patient’s existing symptom burden, the attending did not appear to favor adding another medication immediately, due to concern that it could muddy the clinical picture.
Referral Burden
The neuro-ophthalmology referral should not be interpreted as resolution. The referral may be clinically appropriate, but it also introduces additional burden. It requires further waiting, additional appointments, increased financial cost, more time away from work, further strain on household resources, and another round of reconstructing a complex longitudinal history for a new specialty.
The attending reportedly indicated that the observed ophthalmologic findings appeared relatively minor and expressed uncertainty regarding whether neuro-ophthalmology would ultimately identify a clinically significant abnormality. The referral was therefore framed primarily as an important step in evaluating possible intracranial hypertension and protecting against vision-related complications rather than as a likely source of definitive answers.
This distinction is important. The referral may help answer a specific clinical question, but it does not necessarily answer the stewardship question. The central issue is not whether referral is appropriate. The central issue is whether a clear ownership structure exists if the referral proves unrevealing.
At the conclusion of the encounter, that question remained unresolved.
Continuity Observation
The most significant continuity observation occurred after the clinical encounter, during checkout.
The patient was told during the visit that follow-up should occur in approximately three months. Three months would place follow-up around September. At checkout, however, scheduling reportedly had no availability until January, approximately nine months away.
This created a major discrepancy between the clinical follow-up interval discussed in the room and the actual continuity available through the system.
The patient then asked whether the resident seen that day would still be present by the time follow-up occurred. The patient was informed that the resident was leaving in approximately two weeks.
This changed the meaning of the entire encounter. The patient had spent the visit reconstructing a complex longitudinal history for a physician who would not be present to follow the case, receive the neuro-ophthalmology outcome, interpret any future lumbar puncture decision, or carry the unresolved problem forward.
The issue is not that the resident was leaving. The issue is that this was not made clear to the patient before or during the encounter, despite the patient’s explicitly stated concerns about resident turnover, attending-level care, and continuity.
The patient had previously requested attending-level care because of repeated transitions and the longitudinal nature of the unresolved problem. Yet the patient was again placed in the position of reconstructing the case for a clinician who would soon exit the system.
This is not merely inconvenient. It is structurally meaningful. The patient’s time, energy, work loss, financial strain, and limited sick leave were spent rebuilding continuity inside an encounter that did not itself create stable continuity.
Unresolved Symptoms
The encounter did not meaningfully address the broader constellation of ongoing neurological symptoms beyond the pathway of neuro-ophthalmology evaluation, possible intracranial hypertension assessment, and potential future lumbar puncture.
The patient left with a defined next step and several possible future diagnostic pathways. What remained less clear was how the broader symptom complex would be integrated if those future evaluations failed to provide a unifying explanation.
The patient therefore left with additional diagnostic activity, but without a substantially clearer understanding of the overall explanatory framework of the case or who would ultimately remain responsible for carrying the unresolved clinical question forward.
PaJR Observation
This encounter illustrates the distinction between diagnostic motion and stewardship.
Diagnostic activity occurred throughout the visit. Laboratory testing was obtained, neuro-ophthalmology referral was initiated, possible lumbar puncture was discussed, and medication options were reviewed. Yet the central stewardship question remained largely unchanged.
The encounter did not clarify who would retain longitudinal ownership if neuro-ophthalmology proved unrevealing, if laboratory results remained unremarkable, if lumbar puncture was delayed or deferred, or if symptoms continued without a definitive explanatory finding.
The patient again found themselves functioning as the continuity architecture of the case. The patient reconstructed the history, identified monitoring concerns, tracked longitudinal laboratory trends, clarified provider transitions, and ultimately discovered during checkout that the resident seen during the encounter would be leaving the program within approximately two weeks.
The most important question at the conclusion of the visit was not simply what should happen next. The more consequential question was who would remain responsible if the next step failed to resolve the uncertainty.
Diagnostic systems are generally designed to answer the first question. Stewardship requires answering the second.
That question remained unresolved.
Interpretive Summary
This encounter should not be described as a complete absence of progress. Diagnostic activity occurred, additional data were generated, and future pathways were established. However, movement and stewardship are not the same phenomenon.
A system may obtain laboratory studies, initiate referrals, discuss future testing, and continue generating clinical activity while leaving unresolved the question of who remains responsible for integrating those activities into a coherent longitudinal plan.
The patient did not experience the encounter as a failure of individual clinician behavior. Both the resident and attending physician were described as respectful and engaged throughout the visit. The deeper concern was structural rather than interpersonal.
A complex longitudinal case was again routed through a temporary clinician. A proposed three-month follow-up interval became a practical nine-month scheduling reality. Monitoring occurred only after repeated patient requests. A new referral became the primary next step despite acknowledgement that it might ultimately prove unrevealing. Additional data were generated without substantially changing the explanatory framework of the case.
The encounter reduced neither the complexity of the case nor the uncertainty surrounding it. Instead, much of that uncertainty was redistributed across future appointments, future providers, future specialties, and future testing pathways.
In PaJR terms, the encounter did not eliminate the burden migration described in the prior case study. Rather, it provided another example of it. Diagnostic activity continued, additional observations were generated, and future pathways were established, yet responsibility for integrating those pathways remained difficult to locate.
The system continued to observe the problem while the patient continued to carry much of the burden created by its persistence.
[04/06, 09:11]hu2: Very well described sequence of events as to what challenges current endeavours to generate persistent clinical encounters.
Will cite it here:
